Michael Gold to Receptors, Tumor Necrosis Factor, Type II
This is a "connection" page, showing publications Michael Gold has written about Receptors, Tumor Necrosis Factor, Type II.
Connection Strength
0.240
-
Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial. Heart Rhythm. 2019 05; 16(5):743-753.
Score: 0.152
-
TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells. Eur J Immunol. 2011 Feb; 41(2):335-44.
Score: 0.088